<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <link href="https://cdn.jsdelivr.net/npm/bootstrap@5.1.3/dist/css/bootstrap.min.css" rel="stylesheet" integrity="sha384-1BmE4kWBq78iYhFldvKuhfTAU6auU8tT94WrHftjDbrCEXSU1oBoqyl2QvZ6jIW3" crossorigin="anonymous">
    <title>Drugs Approval</title>
    <link rel="icon" href="img/drugs1.png" type="image/png">
    <script src="https://kit.fontawesome.com/769f430edb.js" crossorigin="anonymous"></script>
    <style>
        a{
            text-decoration: none;
        }
     
    </style>
</head>
<body>
<?php
include 'layout/header.php';
?>
    <div class="container">
        <div class="row">
          <div class="col-md-8 py-5">
            <h1><b>New Drugs Approvals</b></h1>
            <div class="input-group mb-3">
                <input type="text" class="form-control" placeholder="Search News"  aria-describedby="button-addon2">
                <button type="button" class="btn btn-primary">Search</button>
            </div>
            <br>
        
            <div class="container">
                <p>The following drugs have recently been approved by the FDA. Includes newly approved drugs and new indications for drugs already approved.</p>
                <p>See also: <a href="/generic-approvals.html">Generic approvals</a>, <a href="/fda-approval-process.html">Approval process</a>, <a href="/new-indications.html">New indications &amp; dosage forms</a></p>
            
                <div class="ddc-media-list ddc-mgt-4">
                    <div class="ddc-media">
                        <div class="ddc-media-content">
                            <h2 class="ddc-media-title"><a href="/pro/alymsys.html">Alymsys</a> (bevacizumab-maly)  Injection</h2>
                                <p class="drug-subtitle">
                                <b>Company:</b> <a href="/manufacturer/amneal-pharmaceuticals-llc-19.html">Amneal Pharmaceuticals LLC</a><br>
                                <b>Date of Approval:</b> April 13, 2022<br>
                                <b>Treatment for:</b> Colorectal Cancer, Non-Small Cell Lung Cancer, Glioblastoma Multiforme, Renal Cell Carcinoma, Cervical Cancer, Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Cancer<br>
                                </p>
                                <p>Alymsys (bevacizumab-maly) is a vascular endothelial growth factor inhibitor biosimilar to Avastin (bevacizumab) for the treatment of multiple types of cancer including metastatic colorectal cancer; non-small cell lung cancer; glioblastoma; metastatic renal cell carcinoma; cervical cancer; and epithelial ovarian, fallopian tube, or primary peritoneal cancer.</p>
                                <ul class="previous_application">
                                    <li><a href="/newdrugs/fda-approves-alymsys-bevacizumab-maly-biosimilar-avastin-5819.html">FDA Approves Alymsys (bevacizumab-maly), a Biosimilar to Avastin</a> - April 13, 2022</li>
                                    <li><a href="/history/alymsys.html">Alymsys FDA Approval History</a></li>
                                </ul>
                        </div>
                    </div>
                </div>
            </div>
            
            </div>

        <div class="col-md-4 py-5">
            <div class="alert alert-secondary" role="alert">
                <h4>Subscribe to our newsletters</h4>
              <div class="form-check">
                <input class="form-check-input" type="checkbox" value="" id="flexCheckDefault">
                <label class="form-check-label" for="flexCheckDefault">
                    FDA Safety Alerts
                </label>
              </div>
              <div class="form-check">
                <input class="form-check-input" type="checkbox" value="" id="flexCheckDefault">
                <label class="form-check-label" for="flexCheckDefault">
                    Daily MedNews
                </label>
              </div>
              <div class="form-check">
                <input class="form-check-input" type="checkbox" value="" id="flexCheckDefault">
                <label class="form-check-label" for="flexCheckDefault">
                    Monthly Newsletter
                </label>
              </div>
              <div class="form-check">
                <input class="form-check-input" type="checkbox" value="" id="flexCheckDefault">
                <label class="form-check-label" for="flexCheckDefault">
                    I accept the Terms and Privacy Policy
                </label>
              </div>
              <div class="form">
                <div class="input-group mb-3">
                    <input type="text" class="form-control" placeholder="Email Address" aria-label="Email address" aria-describedby="button-addon2">
                    <button class="btn btn-primary" type="button" id="button-addon2">Subscribe</button>
                  </div>

              </div>
            </div>
        </div>
        </div>
    </div>
    <script src="https://cdn.jsdelivr.net/npm/@popperjs/core@2.9.2/dist/umd/popper.min.js" integrity="sha384-IQsoLXl5PILFhosVNubq5LC7Qb9DXgDA9i+tQ8Zj3iwWAwPtgFTxbJ8NT4GN1R8p" crossorigin="anonymous"></script>
    <script src="https://cdn.jsdelivr.net/npm/bootstrap@5.0.2/dist/js/bootstrap.min.js" integrity="sha384-cVKIPhGWiC2Al4u+LWgxfKTRIcfu0JTxR+EQDz/bgldoEyl4H0zUF0QKbrJ0EcQF" crossorigin="anonymous"></script>
</body>
</html>
